These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8326828)

  • 1. Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease.
    Brachova L; Lue LF; Schultz J; el Rashidy T; Rogers J
    Brain Res Mol Brain Res; 1993 Jun; 18(4):329-34. PubMed ID: 8326828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal localization of C1q in preclinical Alzheimer's disease.
    Fonseca MI; Kawas CH; Troncoso JC; Tenner AJ
    Neurobiol Dis; 2004 Feb; 15(1):40-6. PubMed ID: 14751769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization and cell association of C1q in Alzheimer's disease brain.
    Afagh A; Cummings BJ; Cribbs DH; Cotman CW; Tenner AJ
    Exp Neurol; 1996 Mar; 138(1):22-32. PubMed ID: 8593893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner.
    Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A
    Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
    Webster S; Bonnell B; Rogers J
    Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
    Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C1q and C3 mRNA expression in the frontal cortex of Alzheimer's patients.
    Fischer B; Schmoll H; Riederer P; Bauer J; Platt D; Popa-Wagner A
    J Mol Med (Berl); 1995 Sep; 73(9):465-71. PubMed ID: 8528750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
    Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ
    J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation by beta-amyloid in Alzheimer disease.
    Rogers J; Cooper NR; Webster S; Schultz J; McGeer PL; Styren SD; Civin WH; Brachova L; Bradt B; Ward P
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10016-20. PubMed ID: 1438191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.
    Webster S; Glabe C; Rogers J
    Biochem Biophys Res Commun; 1995 Dec; 217(3):869-75. PubMed ID: 8554610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition.
    Fan R; DeFilippis K; Van Nostrand WE
    J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q-calreticulin induced oxidative neurotoxicity: relevance for the neuropathogenesis of Alzheimer's disease.
    Luo X; Weber GA; Zheng J; Gendelman HE; Ikezu T
    J Neuroimmunol; 2003 Feb; 135(1-2):62-71. PubMed ID: 12576225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.
    Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L
    Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
    Kalaria RN; Perry G
    Brain Res; 1993 Dec; 631(1):151-5. PubMed ID: 7507788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Complement Factors C1q, Bb, and H in Normal Pregnancy and Severe Pre-Eclampsia.
    Jia K; Ma L; Wu S; Yang W
    Med Sci Monit; 2019 Sep; 25():7087-7093. PubMed ID: 31541546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C1q does not bind monomeric beta-amyloid.
    Snyder SW; Wang GT; Barrett L; Ladror US; Casuto D; Lee CM; Krafft GA; Holzman RB; Holzman TF
    Exp Neurol; 1994 Jul; 128(1):136-42. PubMed ID: 8070518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of amyloid (A4) protein deposits within the cerebral and cerebellar cortex in Down's syndrome and Alzheimer's disease.
    Mann DM; Jones D; Prinja D; Purkiss MS
    Acta Neuropathol; 1990; 80(3):318-27. PubMed ID: 1698007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the relationship between complement activation and vascular endothelial damage in pregnancy induced hypertension].
    Zheng Y; Chen Z; Yan J
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):152-5. PubMed ID: 8758788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions.
    Tacnet-Delorme P; Chevallier S; Arlaud GJ
    J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.